Table 2 Demographic characteristics of COVID-19 hospitalized patients by vaccination status
Characteristics | All patients (n = 1297) | Vaccine breakthrough (n = 159) | No breakthrough (n = 1138) | OR | 95% CI | P value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Percent | No. | Percent | No. | Percent | ||||||
Age group | |||||||||||
< 5 | 22 | 1.7 | 0 | 0.0 | 22 | 1.9 | NA | NA | NA | ||
5–15 | 3 | 0.2 | 1 | 0.6 | 2 | 0.2 | NA | NA | NA | ||
16–35 | 125 | 9.6 | 23 | 14.5 | 102 | 9.0 | 1.717 | 1.06–2.79 | 0.018 | ||
36–50 | 253 | 19.5 | 25 | 15.7 | 228 | 20.0 | 0.744 | 0.47–1.17 | 0.099 | ||
51–65 | 493 | 38.0 | 58 | 36.5 | 435 | 38.2 | 0.928 | 0.66–1.31 | 0.337 | ||
> 65 | 401 | 30.9 | 52 | 32.7 | 349 | 30.7 | 1.099 | 0.77–1.57 | 0.300 | ||
Gender | |||||||||||
Males | 538 | 41.5 | 91 | 57.2 | 447 | 39.3 | 2.069 | 1.48–2.89 | < 0.001 | ||
Females | 759 | 58.5 | 68 | 42.8 | 691 | 60.7 | |||||
-Co-morbidity | |||||||||||
Diabetes | 437 | 33.7 | 70 | 44.0 | 367 | 32.2 | 1.652 | 1.18–2.31 | 0.002 | ||
Cardio-vascular | 319 | 24.6 | 54 | 34.0 | 265 | 23.3 | 1.694 | 1.19–2.41 | 0.002 | ||
Pulmonary | 64 | 4.9 | 12 | 7.5 | 52 | 4.6 | 1.705 | 0.89–3.27 | 0.061 | ||
Other* | 53 | 4.1 | 8 | 5.0 | 45 | 4.0 | 1.287 | 0.60–2.78 | 0.256 | ||
Vaccine type (n = 202) | |||||||||||
Inactivated | 124 | 61.4 | 101 | 65.2 | 23 | 48.9 | 1.952 | 1.01–3.78 | 0.025 | ||
Viral vector | 55 | 27.2 | 42 | 27.1 | 13 | 27.7 | 0.972 | 0.47–2.02 | 0.465 | ||
mRNA | 23 | 11.4 | 12 | 7.7 | 11 | 23.4 | 0.275 | 0.11–0.67 | 0.003 | ||